Matrixyl

What is Matrixyl?#

Matrixyl is the trade name for palmitoyl pentapeptide-4 (Pal-KTTKS), a synthetic cosmeceutical peptide launched in 2000 by Sederma SAS. It is one of the most widely used peptide active ingredients in anti-aging skincare products worldwide. The peptide consists of a five-amino acid sequence (Lys-Thr-Thr-Lys-Ser) conjugated to a palmitic acid (C16) fatty acid chain that enhances skin penetration.

The KTTKS sequence was identified by Katayama et al. as a fragment of the C-terminal propeptide of type I procollagen that is the minimum sequence necessary for potent stimulation of extracellular matrix production by fibroblasts.

Mechanism of Action#

Matrixyl functions as a matrikine -- a peptide fragment of extracellular matrix proteins that signals to cells to regulate matrix production. The mechanism involves several pathways:

1. Collagen synthesis stimulation: The KTTKS sequence mimics a procollagen I C-propeptide fragment, signaling fibroblasts to increase production of collagen types I and III
2. Fibronectin induction: Simultaneously stimulates fibronectin production, a key structural glycoprotein in the dermal matrix
3. Glycosaminoglycan regulation: Inhibits excess production of dermal glycosaminoglycans associated with photoaged skin
4. Epidermal thickening: Promotes thickening of the epidermal layer, improving skin barrier function

The palmitoyl modification serves as a lipophilic anchor that facilitates penetration through the lipid-rich stratum corneum, delivering the active KTTKS peptide to dermal fibroblasts.

Clinical Evidence#

In a 12-week, double-blind, placebo-controlled, split-face study of 93 women (aged 35-55), topical application of a moisturizer containing 3 ppm Pal-KTTKS provided significant improvement in wrinkle and fine line reduction compared to the moisturizer alone, as assessed by both quantitative image analysis and expert graders (Robinson et al., 2005).

Additional studies have reported reductions in wrinkle depth (18%), fold thickness (37%), and skin rigidity (21%) after 28 days of twice-daily application.

Important Considerations#

Matrixyl is a cosmetic ingredient, not a pharmaceutical drug. While it has a favorable safety profile and clinical evidence for wrinkle reduction, it does not achieve the same magnitude of effect as prescription retinoids or injectable procedures. It is best understood as one component of a comprehensive anti-aging skincare regimen.

Key Research Findings#

Topical Palmitoyl Pentapeptide Provides Improvement in Photoaged Human Facial Skin, published in International Journal of Cosmetic Science (Robinson LR et al., 2005; PMID: 18492182):

12-week, double-blind, placebo-controlled, split-face study of 93 women (aged 35-55) evaluating a moisturizer containing 3 ppm Pal-KTTKS vs the moisturizer alone.

• Significant improvement in wrinkles and fine lines vs placebo by quantitative image analysis
• Expert graders confirmed wrinkle reduction on the Pal-KTTKS-treated side
• Well tolerated with no increased skin redness or barrier damage

Regulation of Extracellular Matrix Production by Chemically Synthesized Subfragments of Type I Collagen Carboxy Propeptide, published in Biochemistry (Katayama K et al., 1991; PMID: 1854722):

Foundational study identifying active peptide fragments within the C-terminal propeptide of type I procollagen that stimulate extracellular matrix production by human lung fibroblasts.

• Identified subfragments R9 and R11 that stimulated collagen and fibronectin production 6-8 fold
• R12 (residues 197-216) containing the overlap region was also active
• Led to identification of KTTKS as the minimum active sequence

Related Reading#

• Matrixyl research studies and evidence
• Matrixyl dosing protocols
• Matrixyl side effects profile
• Argireline research guide
• GHK-Cu research guide